Application Site Atrophy
Conditions
Brief summary
Pilot, interventional, randomized of parallel groups and multicenter clinical trial.
Interventions
DEVICEBelk Device
Knee exoskeleton with electrostimulation
Use the standard rehabilitative treatment
Sponsors
Basque Health Service
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Patients of both sexes. * Patients aged between 18 and 85 years. * Patients with knee arthroplasty in the immediate postoperative period. * Sign in informed consent.
Exclusion criteria
* Physical or psychological pathologies that prevent patient participation. * Tumor arthroplasty. * Knee replacement prosthesis. * Impossibility of holding the device. * Patients with a pacemaker.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of sessions until recovery | An average of 12 weeks | It is considered that the patient has completed the rehabilitation treatment when he has achieved an arc of movement between 0 and 100 degrees of flexion, a quadriceps muscle balance greater than or equal to 4/5 according to MRC (Medical Research Council)and a stable march with crutches. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| March in 10 meters | An average of 12 weeks | Number of patients can be walk 10 meters |
| UP&Go test | An average of 12 weeks | Do the UP&GO test |
| Number of falls during rehabilitation sessions | An average of 12 weeks | Number of falls during rehabilitation sessions |
Countries
Spain
Outcome results
None listed